Psychosocial adaptation and influencing factors among patients with chemotherapy-induced peripheral neuropathy.
Cancer
Chemotherapy-induced peripheral neuropathy
Peripheral neurotoxicity
Psychosocial adaptation
Quality of life
Journal
World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806
Informations de publication
Date de publication:
26 May 2022
26 May 2022
Historique:
received:
11
12
2021
revised:
03
02
2022
accepted:
27
03
2022
entrez:
8
7
2022
pubmed:
9
7
2022
medline:
9
7
2022
Statut:
ppublish
Résumé
Chemotherapy-induced peripheral neuropathy (CIPN) is a severe and long-lasting side effect caused by various anticancer agents that damage sensory, motor and autonomic nerves. It can cause maladaptive behaviors, including disease severity, anxiety, depression, sleep disorders, falls, and social impairment. These disorders have physical, psychological and social effects on patients and can seriously influence their quality of life. To investigate the current situation of psychosocial adaptation to the disease and its influencing factor in patients with CIPN. A convenience sampling method was used to select 233 patients with CIPN in our hospital from February to August 2021. In addition, a cross-sectional survey was conducted using a sociodemographic questionnaire, the Self-Report Psychosocial Adjustment to Illness Scale, and the European Organisation for the Research and Treatment of Cancer Quality of Life CIPN20 (QLQ-CIPN20). Factors influencing psychosocial adaptation in patients with CIPN were analyzed by The psychosocial adaptation score of patients with CIPN was 52.51 ± 13.18. Multivariate analysis showed that autonomic nerves, tumor stage, motor nerves, education level, availability of caregivers, semi-retirement status, CIPN grade were independent risk factors for patients with CIPN ( Patients with CIPN have poor psychosocial adaptation and are affected by a variety of physiological, psychological, and social factors. Patients' adaptive responses should be assessed, and targeted interventions implemented.
Sections du résumé
BACKGROUND
BACKGROUND
Chemotherapy-induced peripheral neuropathy (CIPN) is a severe and long-lasting side effect caused by various anticancer agents that damage sensory, motor and autonomic nerves. It can cause maladaptive behaviors, including disease severity, anxiety, depression, sleep disorders, falls, and social impairment. These disorders have physical, psychological and social effects on patients and can seriously influence their quality of life.
AIM
OBJECTIVE
To investigate the current situation of psychosocial adaptation to the disease and its influencing factor in patients with CIPN.
METHODS
METHODS
A convenience sampling method was used to select 233 patients with CIPN in our hospital from February to August 2021. In addition, a cross-sectional survey was conducted using a sociodemographic questionnaire, the Self-Report Psychosocial Adjustment to Illness Scale, and the European Organisation for the Research and Treatment of Cancer Quality of Life CIPN20 (QLQ-CIPN20). Factors influencing psychosocial adaptation in patients with CIPN were analyzed by
RESULTS
RESULTS
The psychosocial adaptation score of patients with CIPN was 52.51 ± 13.18. Multivariate analysis showed that autonomic nerves, tumor stage, motor nerves, education level, availability of caregivers, semi-retirement status, CIPN grade were independent risk factors for patients with CIPN (
CONCLUSION
CONCLUSIONS
Patients with CIPN have poor psychosocial adaptation and are affected by a variety of physiological, psychological, and social factors. Patients' adaptive responses should be assessed, and targeted interventions implemented.
Identifiants
pubmed: 35801039
doi: 10.12998/wjcc.v10.i15.4843
pmc: PMC9198882
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4843-4855Informations de copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declared that no conflict of interest.
Références
Curr Oncol Rep. 2020 Oct 1;22(12):122
pubmed: 33001322
Brain Behav. 2016 Oct 26;7(1):e00558
pubmed: 28127506
Support Care Cancer. 2021 Feb;29(2):733-739
pubmed: 32447502
Sports Med. 2014 Sep;44(9):1289-304
pubmed: 24927670
Int J Environ Res Public Health. 2021 May 26;18(11):
pubmed: 34073174
Breast. 2020 Dec;54:133-138
pubmed: 33035934
Support Care Cancer. 2019 Sep;27(9):3357-3364
pubmed: 30623244
J Clin Oncol. 2017 Aug 10;35(23):2604-2612
pubmed: 28586243
J Emerg Nurs. 2008 Aug;34(4):340-4
pubmed: 18640416
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 26786536
Appl Neuropsychol Adult. 2021 Sep-Oct;28(5):614-618
pubmed: 31612735
J Consult Clin Psychol. 2005 Apr;73(2):300-11
pubmed: 15796638
Support Care Cancer. 2021 Jun;29(6):2959-2971
pubmed: 33025227
J Clin Med. 2020 Jul 27;9(8):
pubmed: 32727095
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Eur J Cancer Care (Engl). 2019 Jul;28(4):e13051
pubmed: 31033073
J Cancer Surviv. 2021 Aug;15(4):564-575
pubmed: 33089480
Support Care Cancer. 2022 Jan;30(1):95-104
pubmed: 34232392
Cancer Invest. 2021 Sep;39(8):607-620
pubmed: 33826457
J Clin Oncol. 2020 Oct 1;38(28):3325-3348
pubmed: 32663120
Breast Care (Basel). 2021 Jun;16(3):269-275
pubmed: 34248468
Eur J Oncol Nurs. 2018 Oct;36:135-141
pubmed: 30322504
Front Psychol. 2016 Aug 03;7:1162
pubmed: 27536265
Int J Mol Sci. 2019 Mar 22;20(6):
pubmed: 30909387
J Psychosom Res. 1986;30(1):77-91
pubmed: 3701670
Int J Mol Sci. 2021 Feb 17;22(4):
pubmed: 33671327
Support Care Cancer. 2018 May;26(5):1607-1615
pubmed: 29204710
Curr Opin Neurol. 2015 Oct;28(5):500-7
pubmed: 26197027